Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale

J Oral Maxillofac Surg. 2010 Apr;68(4):889-97. doi: 10.1016/j.joms.2009.04.048. Epub 2010 Jan 6.

Authors

Kouji Yamaguchi¹, Takefumi Oizumi, Hiromi Funayama, Hiroshi Kawamura, Shunji Sugawara, Yasuo Endo

Affiliation

¹ Department of Maxillofacial Surgery, Tohoku University Graduate School of Dentistry, Aoba-ku, Sendai, Japan.

PMID: 20056305
DOI: 10.1016/j.joms.2009.04.048

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Aged, 80 and over
Binding, Competitive
Bone Density Conservation Agents / adverse effects*
Bone Density Conservation Agents / metabolism
Bone Density Conservation Agents / therapeutic use
Diphosphonates
Etidronic Acid / adverse effects
Etidronic Acid / analogs & derivatives*
Etidronic Acid / chemistry
Etidronic Acid / metabolism
Etidronic Acid / therapeutic use
Female
Humans
Inflammation Mediators / metabolism
Lipopolysaccharides / metabolism
Mandibular Diseases / chemically induced
Mandibular Diseases / diagnostic imaging
Mandibular Diseases / drug therapy*
Mandibular Diseases / metabolism
Nitrogen
Osteomyelitis / complications
Osteomyelitis / drug therapy*
Osteomyelitis / metabolism
Osteonecrosis / chemically induced
Osteonecrosis / complications
Osteonecrosis / drug therapy*
Osteoporosis, Postmenopausal / complications
Osteoporosis, Postmenopausal / drug therapy*
Radionuclide Imaging
Radiopharmaceuticals
Risedronic Acid
Technetium Compounds
Tooth Extraction / adverse effects

Substances

Bone Density Conservation Agents
Diphosphonates
Inflammation Mediators
Lipopolysaccharides
Radiopharmaceuticals
Technetium Compounds
technetium Tc 99m diphosphonate
Risedronic Acid
Etidronic Acid
Nitrogen